• A
  • A
  • A
日本語 Help
Science and technology information site for articles, patents, researchers information, etc.
Advanced
search
ALL

Synonyms(0)

Find out more technical terms

Thesaurus Map Clips

ー



Please login to MyJ-GLOBAL to use J- GLOBAL.
Please register to create your MyJ-GLOBAL account, if you do not have one.
What is MyJ-GLOBAL?
Login Register now
Number of clips is over the max size. (Max number of Clips: 600)
Close
Reset
Go to 「How to search」 page
Advanced search: Search from
　
　Select basic information for advanced search
Free word
～
Chemical structure search
How to Search
NEW R FG i
C N O S F Cl Br I P X
JSME Molecular Editor by Peter Ertl and Bruno Bienfait
drag out MOL or RXN file
Import

MOLfile format is only available (V3000 format is not available)

              
Details
Related links
Search

Co-authoring Researcher

Co-inventing Researcher

Researcher similar to the Researcher

Article similar to the Researcher

Patent similar to the Researcher

Research Project similar to the Researcher

Article(J-GLOBAL estimation)

Patent(J-GLOBAL estimation)

Rchr
J-GLOBAL ID：200901046473622082   Update date: Mar. 05, 2025

Handa Hiroshi

ハンダ ヒロシ | Handa Hiroshi
Clips
Affiliation and department：
Gunma University Hematology, Graduate School of Medicine

About Gunma University Hematology, Graduate School of Medicine


Job title： Lecturer
Research field  (1)： Other
Research keywords  (4)： 血液検査学 ,  血液腫瘍学 ,  Laboratory Hematology ,  Hematology Oncology
Research theme for competitive and other funds  (7)：
  • 2020 - 2023 急性NK白血病における腫瘍微小環境解析
  • 2014 - 2017 Analyzing role of non-coding RNA in multiple myeloma by using next generation sequnecer
  • 2012 - 2015 Role of AID and MMSET in progression of multiple myeloma
  • 2011 - 2013 Development of long-term culture system for human MDS specific iPS
  • 2010 - 2012 The expression of Toll-like receptor in myelodysplastic syndrome
Show all
Papers (350)：
  • Nanami Gotoh, Tsukasa Oda, Yuya Kitamura, Natsuki Shiraishi, Runa Aoyagi, Ayane Omori, Kota Yanagisawa, Minami Iida, Yua Itoi, Hikaru Negishi, et al. APEX1 Polymorphisms Affect Acute Myeloid Leukemia Risk, and Its Expression Is Involved in Cell Proliferation and Differentiation. International journal of laboratory hematology. 2024
  • 梶田 樹矢, 小川 孔幸, 松本 彬, 柳澤 邦雄, 小林 宣彦, 宮澤 悠里, 武井 寿史, 内海 英貴, 小林 靖子, 酒井 和哉, et al. 当院における免疫原性血栓性血小板減少性紫斑病の診療経験. 日本血液学会学術集会. 2024. 86回. O1-4
  • 吉澤 遼, 小川 孔幸, 柳澤 邦雄, 松本 彬, 西連寺 由起子, 金谷 秀平, 大崎 洋平, 宮澤 悠里, 小林 宣彦, 久保 政之, et al. 経時的ADAMTS13活性測定により繰り返す再発を早期に検知しステロイドのみで再寛解を得たTTP症例. 日本血栓止血学会誌. 2024. 35. 2. 334-334
  • 反町 百花, 小川 孔幸, 松本 彬, Oh Kwan E.E., 今村 健二, 齋藤 慧, 小林 宣彦, 宮澤 悠里, 久保 政之, 酒井 和哉, et al. カプラシズマブ投与中にinhibitor boostingを生じた難治性血栓性血小板減少性紫斑病(TTP)症例. 日本血栓止血学会誌. 2024. 35. 2. 346-346
  • Yasuo Mori, Jun Takizawa, Yuna Katsuoka, Naoki Takezako, Koji Nagafuji, Hiroshi Handa, Junya Kuroda, Kazutaka Sunami, Tomohiko Kamimura, Ryosuke Ogawa, et al. Autologous HSCT with novel agent-based induction and consolidation followed by lenalidomide maintenance for untreated multiple myeloma. Cancer science. 2024
ｍore...
MISC (407)：
  • OHMORI Ayane, KOBAYASHI Nobuhiko, MATSUMURA Ikuko, ISHIHARA Rei, MURAKAMI Yuki, MATSUMOTO Akira, SHIRAISHI Natsuki, GOTOH Nanami, KASAMATSU Tetsuhiro, SAITOH Takayuki, et al. Involvement of laminin-integrin α6 in the growth of multiple myeloma. 日本血液学会学術集会抄録(Web). 2024. 86th
  • 松村郁子, 小田司, 笠松哲光, 大森綺音, 村上有希, 石原領, 松本彬, 後藤七海, 小林宣彦, 宮澤悠里, et al. 多発性骨髄腫におけるRho-GTPaseファミリーRac1の役割の解明と標的にした治療法の検討. 北関東医学会総会プログラム・抄録. 2024. 71st
  • 大森綺音, 小林宣彦, 松村郁子, 石原領, 村上有希, 松本彬, 後藤七海, 笠松哲光, 齋藤貴之, 半田寛. 多発性骨髄腫の増殖におけるラミニン-インテグリンα6の関与. 日本検査血液学会雑誌. 2024. 25
  • 大森綺音, 小林宣彦, 松村郁子, 石原領, 村上有希, 白石菜月, 柳澤宏太, 糸井悠晏, 飯田南美, 根岸光, et al. Involvement of laminin-integrin alpha 6 in the growth of multiple myeloma. International Journal of Myeloma (Web). 2024. 14. 3
  • 早川輝, 早川輝, 佐野利恵, 高橋遥一郎, 大川貴史, 窪理英子, 原田恩, 福田治紀, 横濱章彦, 半田寛, et al. ABO式血液型抗原量低下を示した骨髄異形成症候群の機序の解析. 日本輸血細胞治療学会誌. 2022. 68. 2
ｍore...
Books (5)：
  • これ血液悪性疾患?自分の守備範囲? 非専門医のための見分け方
    医学書院 2010
  • EBM血液疾患の治療2010-2011 形質細胞性白血病に対する治療は
    中外医学社 2010
  • 造血器腫瘍治療 これは困ったぞどうしよう 2版 原発性マクログロブリン血症患者の意識が朦朧としてきた。血清IgM値が11g/dlある。さてどうしよう?
    中外医学社 2010
  • 造血器腫瘍治療-これは困ったぞどうしよう!
    中外医学社 2009
  • 造血器腫瘍治療-これは困ったぞどうしよう!
    中外医学社 2006
Lectures and oral presentations  (66)：
  • Mircro-RNA expression is associated with expression of DNA methyltransferases and anti-apoptotic gene mcl-1 in multiple myeloma and monoclonal gammopathy with undetermined significance (MGUS)
    (European Hematology Association (EHA) 2012)
  • Association between micro-RNA and epigenetic modifiers DNA methyltransferases (DNMTs), histone deacetylases (HDACs) in multiple myeloma (MM) and monoclonal gammmopathy with undetermined significance (MGUS)
    (American Society of Hematology 2012)
  • Mircro-RNA expression is associated with expression of DNA methyltransferases and anti-apoptotic gene mcl-1 in multiple myeloma and monoclonal gammopathy with undetermined significance (MGUS)
    (European Hematology Association (EHA) 2012)
  • Association between micro-RNA and epigenetic modifiers DNA methyltransferases (DNMTs), histone deacetylases (HDACs) in multiple myeloma (MM) and monoclonal gammmopathy with undetermined significance (MGUS)
    (American Society of Hematology 2012)
  • Human telomerase reverse transcriptase (hTERT) expression detected by flow cytometry in CD34 positive progenitor fraction in myelodysplasitc syndorme and acute myeloid leukemia
    (15th Congress of the European Hematology Association 2010)
ｍore...
Education (2)：
  • - 1990 Gunma University Faculty of Medicine School of Medicine
  • - 1990 Gunma University Faculty of Medicine
Professional career (1)：
  • PhD (Gunma University)
Work history (8)：
  • 2001 - 2002 Gunma University University Hospital, Hematology
  • 2001 - 2002 Gunma University Hospital, Division of Hematology
  • 2002 - - 群馬大学医学部保健学科応用検査学助手
  • 2002 - - Gunma University, Faculty of Medicine, School of Health Science
  • 1996 - 1998 Gunma University University Hospital
Show all
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page

TOP

BOTTOM